Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Melissa Kool"'
Autor:
Melissa Kool, L.T. Hoekstra, René R. W. J. van der Hulst, Esther M. Heuts, S. Tuinder, Andrzej Piatkowski, Jop Beugels
Publikováno v:
Annals of Plastic Surgery, 81(5), 523-527. LIPPINCOTT WILLIAMS & WILKINS
Introduction It is known that breast reconstruction improves quality of life (QoL) in women who underwent mastectomy. Previous studies showed that autologous immediate breast reconstruction is as safe as delayed breast reconstruction. However, there
Autor:
Melissa Kool, Anouk J. M. Cornelissen, Shan Shan Qiu, René R. W. J. van der Hulst, Tiara R. Lopez Penha, Esther M. Heuts, Andrzej Piatkowski, Xavier H. A. Keuter
Publikováno v:
Breast Cancer Research and Treatment, 163(2), 281-286. Springer, Cham
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
Purpose Lymphedema is a chronic and disabling sequel of breast cancer treatment that can be treated by lymphatico-venous anastomosis (LVA). Artificial connections between the venous and lymphatic system are performed supermicrosurgically. This prospe
Autor:
Andrzej A. Piatkowski de Grzymala, Melissa Kool, Xavier H. A. Keuter, Shan Shan Qiu, René R. W. J. van der Hulst, Esther M. Heuts, Anouk J. M. Cornelissen
Publikováno v:
Lymphatic research and biology. 16(2)
Purpose: Lymphedema of the arm is one of the most common and underestimated side effects of breast cancer treatment. It is known to negatively affect the quality of life (QoL) in breast cancer survivors. However, there are multiple questionnaires use
Publikováno v:
Clinical Breast Cancer
Clinical Breast Cancer, 18(3), 234-238
Clinical Breast Cancer, 18(3), 234-238
Objectives Medical records are considered the gold standard for accurate treatment information. However, treatment data are increasingly obtained from questionnaires. It can be questioned whether self-reported treatment data are reliable, particularl
Autor:
Judith R. Kroep, Cornelis J.H. van de Velde, Melissa Kool, Gerrit-Jan Liefers, R. Vree, Ilse Jannink, Esther Bastiaannet, Onno R. Guicherit, Perla J Marang-van de Mheen, Joost R.M. van der Sijp
Publikováno v:
The Breast, 27, 62-68
Given increasing numbers of breast cancer survivors, there is an increased focus on quality of life and quality of care. This study aims to investigate whether clinical or patient reported outcomes are most important for perceived quality of care by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262734770cc737a3b1bb27de8dd9e21e
http://hdl.handle.net/1887/112688
http://hdl.handle.net/1887/112688
Autor:
J.W.R. Nortier, E. Meershoek-Klein Kranenbarg, E.J.T. Rutgers, D.B.Y. Fontein, P J Marang-van de Mheen, Melissa Kool, C.J.H. van de Velde
Publikováno v:
The Breast, 24(3), 224-229
Breast (Edinburgh, Scotland), 24(3), 224-229. Churchill Livingstone
Breast (Edinburgh, Scotland), 24(3), 224-229. Churchill Livingstone
Objectives: The standard treatment for hormone-receptor positive, postmenopausal early breast cancer patients is 5 years of adjuvant endocrine therapy. Previous studies demonstrate that prolonging adjuvant endocrine therapy may improve disease-free s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a58da2b64fe8d69f6cd714113f8f872
http://hdl.handle.net/1887/106711
http://hdl.handle.net/1887/106711
Autor:
D.B.Y. Fontein, E.J.T. Rutgers, P J Marang-van de Mheen, J.W.R. Nortier, Melissa Kool, W.M. Meershoek-Klein Kranenbarg, C.J.H. van de Velde
Publikováno v:
European Journal of Surgical Oncology (EJSO). 40:S15-S16
Objectives: The standard treatment for hormone-receptor positive, postmenopausal early breast cancer patients is 5 years of adjuvant endocrine therapy. Previous studies demonstrate that prolonging adjuvant endocrine therapy may improve disease-free s